BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32366552)

  • 61. Correlation between miR-200 Family Overexpression and Cancer Prognosis.
    Liu W; Zhang K; Wei P; Hu Y; Peng Y; Fang X; He G; Wu L; Chao M; Wang J
    Dis Markers; 2018; 2018():6071826. PubMed ID: 30069274
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.
    Xiao Y; Zheng L; Mei Z; Xu C; Liu C; Chu X; Hao B
    Oncotarget; 2017 Nov; 8(59):100449-100458. PubMed ID: 29245991
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyaluronic acid predicts poor prognosis in breast cancer patients: A protocol for systematic review and meta analysis.
    Wu W; Chen L; Wang Y; Jin J; Xie X; Zhang J
    Medicine (Baltimore); 2020 May; 99(22):e20438. PubMed ID: 32481447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis.
    Berlin A; Castro-Mesta JF; Rodriguez-Romo L; Hernandez-Barajas D; González-Guerrero JF; Rodríguez-Fernández IA; González-Conchas G; Verdines-Perez A; Vera-Badillo FE
    Urol Oncol; 2017 Aug; 35(8):499-506. PubMed ID: 28648414
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
    Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
    Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy.
    Wang Y; Xu F; Pan J; Zhu Y; Shao X; Sha J; Wang Z; Cai Y; Liu Q; Dong B; Xue W; Huang Y
    BMC Cancer; 2016 May; 16():329. PubMed ID: 27222030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
    Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
    Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
    Tang LQ; Hu DP; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Wen SH; Peng YT; Chen WH; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mai HQ
    PLoS One; 2015; 10(4):e0122965. PubMed ID: 25874450
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
    Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z
    Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review.
    Ou Y; Huang J; Yang L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30389711
    [No Abstract]   [Full Text] [Related]  

  • 72. Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.
    Liu ZQ; Fang JM; Xiao YY; Zhao Y; Cui R; Hu F; Xu Q
    Int J Clin Exp Med; 2015; 8(2):2289-98. PubMed ID: 25932165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.
    Leuzzi G; Galeone C; Gisabella M; Duranti L; Taverna F; Suatoni P; Morelli D; Pastorino U
    Tumori; 2016 Oct; 102(5):441-449. PubMed ID: 27292573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.
    Borkowetz A; Froehner M; Rauner M; Conrad S; Erdmann K; Mayr T; Datta K; Hofbauer LC; Baretton GB; Wirth M; Fuessel S; Toma M; Muders MH
    Int J Cancer; 2020 May; 146(9):2619-2627. PubMed ID: 31509606
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.
    Luo H; Li S; Zhao M; Sheng B; Zhu H; Zhu X
    Oncotarget; 2017 May; 8(22):36845-36856. PubMed ID: 28415663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
    Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
    Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.
    Gu X; Gao X; Li X; Qi X; Ma M; Qin S; Yu H; Sun S; Zhou D; Wang W
    Sci Rep; 2016 Feb; 6():22089. PubMed ID: 26912340
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic Role of Pretreatment C-Reactive Protein to Albumin Ratio in Urological Cancers: A Systematic Review and Meta-Analysis.
    Wu M; Zhou Y; Chen Q; Yu Z; Gu H; Lin P; Li Y; Liu C
    Front Oncol; 2022; 12():879803. PubMed ID: 35480099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.